2
Total investments
0
Early stage
1
Mid stage
0
Late stage
13y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2018
Aquilon Pharma is engaged in the improvement of the efficacy of inhaled drugs by developing value-added medicines.
Experience · 6 entries
All (6)
Investments (2)
Founder (2)
Board (2)
2018
Board Member
Dec 2018
Aquilon Pharma is engaged in the improvement of the efficacy of inhaled drugs by developing value-added medicines.
2016
P
P&L Projects BV
Owner
May 2016
Managing Director
May 2016
EuMEA-HealthConnect creates successful partnerships between product developers and commercialisation companies in Europe, Middle East and Africa. EuMEA-HealthConnect finds, analyses and selects excellent pharmaceutical products and health care solutions that can add value to the health care environment in the selected territories.
EuMEA-HealthConnect brings these products to a network of independent, locally well embedded Health Care companies across Europe, Middle East and Africa. This Connection is made after thorough assessment of the fit between supplier and commercial entity, and therefore offers a better chance for success. We believe that the expertise we have in EuMEA-HealthConnect allows us, following an assessment along certain criteria, to create winning alliances.
2013
C
Cipla Holding BV
Member of the Board
Aug 2013
2004
P
P&L Consulting
Owner
Sep 2004
Show all 6 entries ↓
